imatinib mesylate has been researched along with Hypercalcemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Junyavoraluk, A; Owattanapanich, W; Rujirachun, P; Sirinvaravong, S; Suvannarerg, V | 1 |
| Hyodo, H; Ito, T; Katayama, Y; Kimura, A; Miyoshi, N; Niimi, H; Tanaka, H | 1 |
| Al-Kindy, S; Al-Moundhri, MS; Al-Thahli, K; Rao, L; Salam, J | 1 |
| Beckers, MM; Slee, PH | 1 |
1 review(s) available for imatinib mesylate and Hypercalcemia
| Article | Year |
|---|---|
Leukemic arthritis and severe hypercalcemia in a man with chronic myeloid leukemia: a case report and review of the literature.
Topics: Adult; Antineoplastic Agents; Arthritis; Blast Crisis; Humans; Hypercalcemia; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male | 2018 |
3 other study(ies) available for imatinib mesylate and Hypercalcemia
| Article | Year |
|---|---|
Use of imatinib mesylate for favorable control of hypercalcemia mediated by parathyroid hormone-related protein in a patient with chronic myelogenous leukemia at blast phase.
Topics: Aged; Antineoplastic Agents; Benzamides; Blast Crisis; Bone Marrow Cells; Female; Humans; Hypercalcemia; Hyperplasia; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Parathyroid Hormone-Related Protein; Piperazines; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2005 |
Metastatic gastrointestinal stromal tumor and hypercalcemia in a patient with ulcerative colitis.
Topics: Antineoplastic Agents; Benzamides; Colitis, Ulcerative; Gastrointestinal Stromal Tumors; Humans; Hypercalcemia; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rectum; Treatment Outcome | 2006 |
Hypercalcaemia in a patient with a gastrointestinal stromal tumour.
Topics: Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Female; Gastrointestinal Stromal Tumors; Humans; Hypercalcemia; Imatinib Mesylate; Middle Aged; Pamidronate; Peritoneal Neoplasms; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines | 2007 |